Intravenous immunoglobulin (IVIG) therapy can be life-saving for those with PANS but health insurance denials are common and access to care can be extremely difficult.
Learn more about:
What PANS is and why IVIG is used
Why access to IVIG is difficult for many families
A study sponsored by BIC to investigate PANS families’ journeys to and with IVIG
Clinical and public policy implications of this research
Meet our Guest Speakers:
Warris Bokhari, MD is a physician, entrepreneur, and CEO & Co-Founder of Claimable, a health-tech company focused on helping patients and families challenge wrongful insurance denials.
Denise Calaprice, PhD, is the Co-founder & Senior Program Advisor at the Brain Inflammation Collaborative. After receiving her Bachelor’s degree in Biology from Harvard University and her MS and PhD from Princeton, Dr. Denise Calaprice became an NIH fellow at Columbia University’s College of Physicians and Surgeons in the departments of Clinical and Genetic Epidemiology and Child Psychiatry.
Angela Tang, MD FACP, obtained her MD from Columbia University and trained in internal medicine at Harbor-UCLA Medical Center. She has taught internal medicine and family practice residents at St. Mary Medical Center, Long Beach and Santa-Monica UCLA Medical Center, and she is an Adjunct Clinical Associate Professor with Stanford University’s Immune Behavioral Health Clinic.
Engage with us!
Please sign up for our newsletter to receive notifications on upcoming webinars, and the latest news related to neuroinflammation research.
You will also receive invitations to upcoming webinars so you can participate in the discussions and Q&A sessions.
